eli lilly weight loss - Search News

News

Eli Lilly Stock Drops on Weight-Loss Pill Data

U.S. News & World Report · 2h

New Weight Loss Pill From Eli Lilly Shows Promise in Early Study

FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study. Taken at the highest dose, orforglipron helped patients lose an average 27.3 pounds, or 12.4% of their body weight, over 72 weeks.

Indianapolis Star on MSN · 14h

Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

CBS News on MSN · 17h

Eli Lilly weight loss pill shows promise in latest clinical trial, company says

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly Stock Dives

Barron's on MSN · 1h

Did Eli Lilly Stock Just Have Its Novo Nordisk Moment?

Some would say Eli Lilly just had its Novo Nordisk moment. Analysts mostly agree that the selloff in Lilly shares after the company released disappointing data on its experimental weight-loss pill was overdone. Nonetheless, many analyst trimmed their price targets on shares.

Eli Lilly: 50% Upside For LLY Stock?

In the wake of this sell-off, a critical question arises about whether LLY stock represents a buying opportunity.

MarketWatch · 19h

Health Care Down After Eli Lilly Earnings -- Health Care Roundup

Shares of Eli Lilly plunged after the drug maker reported less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a blockbuster. The pill helped people lose up to about 12% of their body weight after more than a year of treatment.

7hon MSN

New weight loss pill more ‘tolerable’ than jabs shown to be effective in key trial

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

1d

Eli Lilly Q2 Earnings: Ignore Oral Weight Loss Bombshell, This Is A Buy The Dip Moment

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

2d

Novo Nordisk's Weight Loss Challenge in Five Charts

Novo, valued at $650 billion in June last year, has shed over two-thirds of its value since. Its latest market cap is around ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results